ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GLMD Galmed Pharmaceuticals Ltd

0.325001
-0.0052 (-1.57%)
Last Updated: 14:20:49
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Galmed Pharmaceuticals Ltd GLMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0052 -1.57% 0.325001 14:20:49
Open Price Low Price High Price Close Price Prev Close
0.349 0.32 0.349 0.3302
more quote information »

Recent News

Date Time Source Heading
3/15/202409:00PRNUSGalmed Announces Grant of New Patent for the Combination of..
2/14/202414:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202416:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/30/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/22/202316:48EDGAR2Form POS AM - Post-Effective amendments for registration..
11/20/202316:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/20/202316:32PRNUSGalmed Announces a delay in the initiation of its Primary..
11/01/202316:15EDGAR2Form POS AM - Post-Effective amendments for registration..
9/26/202308:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/26/202308:30PRNUSGalmed Announces Allowance of New Patent for Aramchol for..
9/22/202316:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202316:05PRNUSGalmed Pharmaceuticals Announces Receipt of Nasdaq Minimum..
9/21/202307:30EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
9/20/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/13/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202316:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/02/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/21/202310:12EDGAR2Form SC 13G - Statement of acquisition of beneficial..
7/18/202309:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/18/202309:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
7/14/202309:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/14/202309:30PRNUSGalmed Pharmaceuticals Announces Pricing of $7 Million..
7/13/202317:08EDGAR2Form F-1/A - Registration statement for certain foreign..
7/12/202317:29EDGAR2Form F-1/A - Registration statement for certain foreign..
7/10/202308:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/10/202308:00PRNUSGalmed to employ OnKai's disruptive Artificial Intelligence..
6/28/202308:40EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
6/28/202308:37EDGAR2Form F-1/A - Registration statement for certain foreign..
6/01/202308:00PRNUSGalmed Pharmaceuticals Reports First Quarter 2023 Financial..
5/09/202307:00PRNUSGalmed Announces Initiation of a Clinical Development..
3/29/202317:00PRNUSGalmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F..

Your Recent History

Delayed Upgrade Clock